A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure-Reference-Cited by-同舟云学术

A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure

Published:2020-12-14 Issue:14 Volume:61 Page:12
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Li Guorong¹,Nottebaum Astrid F.²,Brigell Mitchell³,Navarro Iris D.¹,Ipe Ute²,Mishra Sarthak²,Gomez-Caraballo Maria¹,Schmitt Heather¹,Soldo Brandi³,Pakola Steve³,Withers Barbara³,Peters Kevin G.³,Vestweber Dietmar²,Stamer W. Daniel¹

Affiliation:

1. Department of Ophthalmology, Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States

2. Max Planck Institute of Molecular Biomedicine, Muenster, Germany

3. Aerpio Pharmaceuticals, Inc., Cincinnati, Ohio, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitination of VE-cadherin regulates inflammation-induced vascular permeability in vivo;EMBO Reports;2024-08-07

2. Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment;Russian Ophthalmological Journal;2024-07-02

3. Rare genetic variation in VE-PTP is associated with central serous chorioretinopathy, venous dysfunction and glaucoma;2024-05-09

4. Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma;Current Medicinal Chemistry;2024-04

5. Eye Disease Genetics and Therapeutics;Essentials in Ophthalmology;2024